Skip to content

Public FDA record

Z-2040-2023: EliA GliadinDP IgG Well in the Phadia 2500EE instrument (Material Number 12410002) EliA GliadinDP IgG is

Recall record Z-2040-2023 for Phadia US Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2040-2023
Company in FDA record
Phadia US Inc
FDA classification date
Jun 30, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Higher reported results when running EliA GliadinDP IgG Well on the instruments Phadia 2500EE compared to running EliA GliadinDP IgG Well on Phadia 250 instrument

Source facts

Action
Themofisher Scientific/Phadia US issued Urgent Medical Device Recall Letter-Medical Device Field Safety Notice issued May 1, 2023. Letter states reason for recall, health risk and action to take: d13 EliA U/mL (due to risk of false positive EliA GliadinDP IgG results in this range) according to your internal procedures. Log files may only be available for analysis for a limited timeframe on the Phadia Laboratory System due to storage and maintenance restrictions and may not cover the entire timeframe of the Instrument message log. " As noted above in section 1.3, also review test results for Total IgA and EliA Celikey IgA (if tested) to identify potential IgA deficient patients. " Should you need help, contact Phadia US Technical Support who can further assist in collecting log files and aid in identifying the potentially impacted test results. 2) Use of the EliA GliadinDP IgG Well on Phadia 2500EE can continue as detailed in the user manual and the DfU with the following recommendations: " For EliA GliadinDP IgG results that fall in the range of e10 to d13 EliA U/mL (due to risk of false positive EliA GliadinDP IgG results) and are IgA deficient: a. Verify positive EliA GliadinDP IgG results using a Phadia 250 instrument if available. Use the result generated on the Phadia 250 to report patient results in line with the user manual and DfU. b. As another option, you may wish to verify positive EliA GliadinDP IgG results by running EliA Celikey IgG on your existing, Phadia 2500EE. It is important to note that EliA Celikey IgG is not a direct alternative for EliA GliadinDP IgG and results generated are not readily interchangeable. Both EliA tests are designed to assist in the diagnosis of celiac disease. Further scientific background on this recommendation can be provided by Phadia s US Technical Support team. c. If you do not have direct access to a Phadia 250 instrument in your laboratory or utilize EliA Celikey IgG, please contact Phadia s US Technical Suppor
Initiated
2023-05-01
Root cause
Under Investigation by firm
Distribution
US: CA, NJ, MI
Recall number
Z-2040-2023
Recall status
Open, Classified
CDRH record ID
200505
FDA classified
2023-06-30
Recall event number
92365

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗